<p>Enzymatic activity of MMP-2/9 under the treatments of artemether (300 µmol/L), shRNA-VCAM-1 and artemether combined with shRNA-VCAM-1 was investigated by fluorescently quenched gelatin assay. The activity of the MMPs was expressed as picomoles substrate/s. The activity of both MMPs was inhibited significantly by artemether and shRNA-VCAM-1 compared with the control group. Artemether+shRNA-VCAM-1 displayed even greater inhibitory effect on enzymatic activity over single artemether or shRNA-VCAM-1 treatments. *<i>P</i><0.05 (compared with control group); <sup>#</sup><i>P</i><0.05 (compared with artemether or shRNA-VCAM-1 group). <i>n</i> = 4.</p
The aim of this study was to evaluate the effect of different concentrations of 2-hydroxyethyl metha...
<p>Perfusion of the general proteinase agonist 4-aminophenylmercuric acetate (APMA) increases latent...
The aim of this study was to investigate the hepatocellular regeneration ability of artemether in ex...
<p>Enzymatic activity of MMP-2/9 under the treatments of artemether (0, 150, 300, 600 µmol/L) was in...
<p>U87 cells were treated with artemether of 300 µmol/L, shRNA transfected or treated with both. Ser...
<p>(A) U87 cells were treated with artemether (300 µmol/L) and shRNA-VCAM-1 alone or in combination....
<p>U87 cells were treated with atemether at various concentrations (0 µmol/L, 150 µmol/L, 300 µmol/L...
<p>The schematic diagram demonstrates the effects of artemether and shRNA-VCAM-1 on the malignant be...
<p>(A) U87 cells were treated with artemether of 300 µmol/L, shRNA transfected or treated with both....
Gelatinase B or matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) is increased in inflammatory proce...
<p>Enzyme activity in the presence of 100 μM compound (MMV# shown) was compared to activity of the e...
Abstract: Different common drugs (Meloxicam, Tenoxicam and Piroxicam, and sodium alendro-nate) were ...
<p>(A) The influence of minocycline, azithromycin, bortezomib and SB-3CT on the activation of proMMP...
Excessive breakdown of extracellular matrix by metalloproteinases (MMPs) may lead to atherosclerosis...
Toth M, Bernardo MM, Gervasi DC, et al. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergis...
The aim of this study was to evaluate the effect of different concentrations of 2-hydroxyethyl metha...
<p>Perfusion of the general proteinase agonist 4-aminophenylmercuric acetate (APMA) increases latent...
The aim of this study was to investigate the hepatocellular regeneration ability of artemether in ex...
<p>Enzymatic activity of MMP-2/9 under the treatments of artemether (0, 150, 300, 600 µmol/L) was in...
<p>U87 cells were treated with artemether of 300 µmol/L, shRNA transfected or treated with both. Ser...
<p>(A) U87 cells were treated with artemether (300 µmol/L) and shRNA-VCAM-1 alone or in combination....
<p>U87 cells were treated with atemether at various concentrations (0 µmol/L, 150 µmol/L, 300 µmol/L...
<p>The schematic diagram demonstrates the effects of artemether and shRNA-VCAM-1 on the malignant be...
<p>(A) U87 cells were treated with artemether of 300 µmol/L, shRNA transfected or treated with both....
Gelatinase B or matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) is increased in inflammatory proce...
<p>Enzyme activity in the presence of 100 μM compound (MMV# shown) was compared to activity of the e...
Abstract: Different common drugs (Meloxicam, Tenoxicam and Piroxicam, and sodium alendro-nate) were ...
<p>(A) The influence of minocycline, azithromycin, bortezomib and SB-3CT on the activation of proMMP...
Excessive breakdown of extracellular matrix by metalloproteinases (MMPs) may lead to atherosclerosis...
Toth M, Bernardo MM, Gervasi DC, et al. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergis...
The aim of this study was to evaluate the effect of different concentrations of 2-hydroxyethyl metha...
<p>Perfusion of the general proteinase agonist 4-aminophenylmercuric acetate (APMA) increases latent...
The aim of this study was to investigate the hepatocellular regeneration ability of artemether in ex...